Fundraising Fox
/Companies
Sign in

Ifmthera

Cambridge, US · Founded 2015 · 11 employees on LinkedIn · 2 known investors

Find your way into Ifmthera

Sign up to find every way you can get introduced to Ifmthera

  • Your email: who you already know at Ifmthera, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Ifmthera team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

IFM Therapeutics develops small-molecule drugs that target the innate immune system to treat inflammation-driven diseases and cancer. The company operates through independently financed R&D subsidiaries, each advancing programs aimed at key control nodes of innate immunity such as NLRP3 and cGAS/STING.

BiotechHealthtech

Founders & leadership

Ifmthera was founded in 2015 by Gary D. Glick.

GDGary D. Glick
Gary D. GlickFounderExecutive Officer, Director at Scorpion Therapeutics
HMH. Martin Seidel
H. Martin SeidelChief Executive Officer

Board

JFJean-Francois Formela
Jean-Francois FormelaBoard directorPartner at Atlas Venture

Investors · 2

Abingworth✓ confirmed by IfmtheraLondon · $15M – $30M

How we know: the company's own site · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$17.1M disclosed across 1 round · 2016

▶$17.1MraisedJun 2016 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gary GlickExecutive Officer, Director
  • Jean-Francois FormelaDirector
Amount sold
$17.1M
First sale
Jun 2016
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Ifmthera went on to found or lead other companies.

Jean-François FormelaDirectorFounded Korro BioJohn LeonardBoard MemberFounded Intellia Therapeutics

Frequently asked questions

What does Ifmthera do?
IFM Therapeutics develops small-molecule drugs that target the innate immune system to treat inflammation-driven diseases and cancer. The company operates through independently financed R&D subsidiaries, each advancing programs aimed at key control nodes of innate immunity such as NLRP3 and cGAS/STING.
Who founded Ifmthera?
Ifmthera was founded by Gary D. Glick in 2015.
Who are Ifmthera's investors?
Ifmthera's investors include Atlas Venture, Abingworth.
How much funding has Ifmthera raised?
Ifmthera has disclosed $17.1M raised across 1 round.
Where is Ifmthera headquartered?
Ifmthera is headquartered in Cambridge, US.